2nd SOHO Italian Conference

http://www.sohoitaly.it/

 

2nd SOHO Italian Conference
A

Updates on Waldenstrom Macroglobulinemia: Does Ibrutinib Improve OS/PFS in Treatment-Naïve Disease? Is Rituximab the Best Maintenance Option? Can We Achieve CR With Zanubrutinib?

By 2nd SOHO Italian Conference FEATURING Alessandra Tedeschi
By 2nd SOHO Italian Conference FEATURING Alessandra Tedeschi
23 views
January 27, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter
Lymphoma
15:16
2nd SOHO Italian Conference

Updates on HL: Pembro Mono in Untreated Patients, Brentuximab Vedoti…

Feat. A. Pinto
10:28
2nd SOHO Italian Conference

Genomics & DLBCL: How Do Alterations of Ribosomal Protein Genes …

Feat. E. Derenzini
11:13
2nd SOHO Italian Conference

Updates on Waldenstrom Macroglobulinemia: Does Ibrutinib Improve OS/…

Feat. A. Tedeschi
15:14
2nd SOHO Italian Conference

How I Treat Lymphomas: Is 1L Obi+Chemo Beneficial for PFS in FL? RIT…

Feat. S. Luminari
12:29
2nd SOHO Italian Conference

Managing Hodgkin Lymphoma: PET Adapted Strategies, Applying ECHELON-…

Feat. J. Leonard
19:44
2nd SOHO Italian Conference

How I Treat DLBCL in 2020: Who Shouldn't Get Standard Treatment…

Feat. .